CARPANESE, DEBORA
 Distribuzione geografica
Continente #
NA - Nord America 1.255
EU - Europa 225
AS - Asia 114
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.595
Nazione #
US - Stati Uniti d'America 1.255
IT - Italia 124
CN - Cina 75
IE - Irlanda 31
VN - Vietnam 26
FI - Finlandia 21
SE - Svezia 14
DE - Germania 11
FR - Francia 9
GB - Regno Unito 6
IN - India 6
NL - Olanda 3
IR - Iran 2
UA - Ucraina 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
DK - Danimarca 1
HK - Hong Kong 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 1.595
Città #
Fairfield 214
Chandler 171
Woodbridge 157
Ashburn 98
Seattle 85
Ann Arbor 79
Cambridge 70
Wilmington 65
Padova 60
Houston 51
Dublin 31
Dong Ket 26
San Diego 23
Beijing 22
Des Moines 19
Medford 19
Princeton 19
Helsinki 11
Nanjing 10
Milan 9
Boardman 8
Roxbury 8
Cagliari 6
Columbus 6
Los Angeles 6
Paris 5
Pune 5
Guangzhou 4
Legnaro 4
London 4
New York 4
Changsha 3
Duncan 3
Falls Church 3
Nanchang 3
Rome 3
Shanghai 3
Amsterdam 2
Calalzo di Cadore 2
Casalecchio di Reno 2
Genoa 2
Hebei 2
Montegrotto Terme 2
Ogden 2
Orsay 2
Selvazzano Dentro 2
Shenyang 2
Tappahannock 2
Washington 2
Baltimore 1
Borås 1
Bratislava 1
Clearwater 1
Copenhagen 1
Falkenstein 1
Fuzhou 1
Harbin 1
Hefei 1
Hyderabad 1
Kuala Lumpur 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Monte di Procida 1
Munich 1
Norwalk 1
Orange 1
Phoenix 1
Rockville 1
San Francisco 1
Taipei 1
Tianjin 1
Tollegno 1
Torino 1
Venice 1
Verona 1
Vienna 1
Warsaw 1
Zhengzhou 1
Totale 1.371
Nome #
The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis 123
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer 116
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells 115
[99mTc(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 108
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines 107
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 106
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 102
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer 101
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of αvβ3 Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies 96
TcIII-based mixed complexes for the design and the development of new SPECT tracers 91
A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts 87
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 85
A natural polymer (NPX) as a new adjuvant for breast cancer vaccination strategies 80
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 60
Initial in vitro interspecies comparison of hepatic metabolism of the investigational anticancer agent 6-(7-nitro-2,1,3-benzoxadiazol-4- ylthio)hexanol (NBDHEX) 59
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine 56
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents. 29
Synthesis a new radiopharmaceutical for prostate cancer SPECT imaging 27
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical 20
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 19
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA. 18
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation" 13
Totale 1.618
Categoria #
all - tutte 5.761
article - articoli 4.884
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 0 38 29
2019/2020208 28 5 2 11 19 14 33 25 32 18 12 9
2020/2021322 7 15 29 4 4 9 22 26 25 39 37 105
2021/2022267 53 19 22 11 12 14 13 31 10 11 12 59
2022/2023338 37 46 13 53 56 56 4 13 31 8 17 4
2023/2024191 8 29 30 13 21 27 23 15 15 10 0 0
Totale 1.618